sorafenib has been researched along with codeine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (codeine) | Trials (codeine) | Recent Studies (post-2010) (codeine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 4,815 | 730 | 952 |
| Protein | Taxonomy | sorafenib (IC50) | codeine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 10 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 10 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.105 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Edginton, AN | 1 |
1 review(s) available for sorafenib and codeine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and codeine
| Article | Year |
|---|---|
Using Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation.
Topics: Analgesics, Opioid; Antineoplastic Agents; Breast Feeding; Codeine; Computer Simulation; Cytochrome P-450 CYP2D6; Drug Overdose; Hand-Foot Syndrome; Humans; Milk, Human; Models, Biological; Pharmacology, Clinical; Sorafenib | 2018 |